Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 926567, 12 pages
http://dx.doi.org/10.1155/2015/926567
Review Article

Transcriptome and Molecular Endocrinology Aspects of Epicardial Adipose Tissue in Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Observational Studies

1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, 5th floor Shariati Hospital, North Kargar Avenue, Tehran 1411413137, Iran
3Department of Medicine, Section of Endocrinology, Nutrition, and Diabetes, Vitamin D, Skin and Bone Research Laboratory, Boston University Medical Center, Boston, MA, USA

Received 6 June 2015; Revised 20 September 2015; Accepted 7 October 2015

Academic Editor: Kazuhiko Kotani

Copyright © 2015 Zhila Maghbooli and Arash Hossein-nezhad. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. G. Farb and N. Gokce, “Visceral adiposopathy: a vascular perspective,” Hormone Molecular Biology and Clinical Investigation, vol. 21, pp. 125–136, 2015. View at Google Scholar
  2. S. Lemieux, A. Bédard, M.-É. Piché, S. J. Weisnagel, L. Corneau, and J. Bergeron, “Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes,” Clinical Endocrinology, vol. 74, no. 3, pp. 340–345, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Murri, M. Insenser, M. R. Bernal-Lopez, P. Perez-Martinez, H. F. Escobar-Morreale, and F. J. Tinahones, “Proteomic analysis of visceral adipose tissue in pre-obese patients with type 2 diabetes,” Molecular and Cellular Endocrinology, vol. 376, no. 1-2, pp. 99–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Osawa, T. Miyoshi, Y. Koyama et al., “Differential association of visceral adipose tissue with coronary plaque characteristics in patients with and without diabetes mellitus,” Cardiovascular Diabetology, vol. 13, no. 1, article 61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Smith, A.-L. Borel, J.-A. Nazare et al., “Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE me IAA study,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 5, pp. 1517–1525, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. McGavock, R. G. Victor, R. H. Unger, and L. S. Szczepaniak, “Adiposity of the heart, revisited,” Annals of Internal Medicine, vol. 144, no. 7, pp. 517–524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Gaborit, I. Abdesselam, and A. Dutour, “Epicardial fat: more than just an epi phenomenon?” Hormone and Metabolic Research, vol. 45, no. 13, pp. 991–1001, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Iacobellis, D. Corradi, and A. M. Sharma, “Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart,” Nature Clinical Practice Cardiovascular Medicine, vol. 2, no. 10, pp. 536–543, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Mazurek, L. Zhang, A. Zalewski et al., “Human epicardial adipose tissue is a source of inflammatory mediators,” Circulation, vol. 108, no. 20, pp. 2460–2466, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Iacobellis and F. Leonetti, “Epicardial adipose tissue and insulin resistance in obese subjects,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 11, pp. 6300–6302, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. S. W. Rabkin, “The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis,” Metabolic Syndrome and Related Disorders, vol. 12, no. 1, pp. 31–42, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Iacobellis and A. M. Sharma, “Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome,” Current Pharmaceutical Design, vol. 13, no. 21, pp. 2180–2184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Benjamini, D. Drai, G. Elmer, N. Kafkafi, and I. Golani, “Controlling the false discovery rate in behavior genetics research,” Behavioural Brain Research, vol. 125, no. 1-2, pp. 279–284, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Reiner, D. Yekutieli, and Y. Benjamini, “Identifying differentially expressed genes using false discovery rate controlling procedures,” Bioinformatics, vol. 19, no. 3, pp. 368–375, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Franceschini, D. Szklarczyk, S. Frankild et al., “STRING v9.1: protein-protein interaction networks, with increased coverage and integration,” Nucleic Acids Research, vol. 41, no. 1, pp. D808–D815, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. R. M. Agra, E. Teijeira-Fernández, D. Pascual-Figal et al., “Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients,” European Journal of Clinical Investigation, vol. 44, no. 1, pp. 29–37, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Atalar, B. Vural, C. Ciftci et al., “11beta-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease,” Genetics and Molecular Research, vol. 11, no. 3, pp. 3122–3132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. R. Baker, A. L. Harte, N. Howell et al., “Epicardial adipose tissue as a source of nuclear factor-κB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease,” Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 1, pp. 261–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. Baker, N. F. D. Silva, D. W. Quinn et al., “Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease,” Cardiovascular Diabetology, vol. 5, article 1, 2006. View at Google Scholar · View at Scopus
  21. C. Bambace, A. Sepe, E. Zoico et al., “Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes,” Heart and Vessels, vol. 29, no. 1, pp. 42–48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Bambace, M. Telesca, E. Zoico et al., “Adiponectin gene expression and adipocyte diameter: a comparison between epicardial and subcutaneous adipose tissue in men,” Cardiovascular Pathology, vol. 20, no. 5, pp. e153–e156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Cappellano, F. Uberti, P. P. Caimmi et al., “Different expression and function of the endocannabinoid system in human epicardial adipose tissue in relation to heart disease,” Canadian Journal of Cardiology, vol. 29, no. 4, pp. 499–509, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. R. B. Castro, C. A. Longui, C. D. Faria et al., “Tissue-specific adaptive levels of glucocorticoid receptor alpha mRNA and their relationship with insulin resistance,” Genetics and Molecular Research, vol. 11, no. 4, pp. 3975–3987, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Dozio, G. Dogliotti, A. E. Malavazos et al., “IL-18 level in patients undergoing coronary artery bypass grafting surgery or valve replacement: which link with epicardial fat depot?” International Journal of Immunopathology and Pharmacology, vol. 25, no. 4, pp. 1011–1020, 2012. View at Google Scholar · View at Scopus
  26. E. Dozio, A. E. Malavazos, E. Vianello et al., “Interleukin-15 and soluble interleukin-15 receptor α in coronary artery disease patients: association with epicardial fat and indices of adipose tissue distribution,” PLoS ONE, vol. 9, no. 3, Article ID e90960, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Dutour, V. Achard, H. Sell et al., “Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease,” Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 2, pp. 963–967, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Eiras, E. Teijeira-Fernández, A. Salgado-Somoza et al., “Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression,” Cytokine, vol. 51, no. 2, pp. 207–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Eiras, E. Teijeira-Fernández, L. G. Shamagian, A. L. Fernandez, A. Vazquez-Boquete, and J. R. Gonzalez-Juanatey, “Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue,” Cytokine, vol. 43, no. 2, pp. 174–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. N. Fain, H. S. Sacks, B. Buehrer et al., “Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots,” International Journal of Obesity, vol. 32, no. 5, pp. 810–815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Fandiño-Vaquero, A. Fernández-Trasancos, E. Álvarez et al., “Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or inflammation in coronary artery disease,” Journal of Membrane Science, vol. 467, pp. 281–288, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Gao, S. Mi, F. Zhang et al., “Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis,” Cardiovascular Diabetology, vol. 10, article 87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Gormez, A. Demirkan, F. Atalar et al., “Adipose tissue gene expression of adiponectin, tumor necrosis factor-α and leptin in metabolic syndrome patients with coronary artery disease,” Internal Medicine, vol. 50, no. 8, pp. 805–810, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Iacobellis, C. R. Di Gioia, M. Di Vito et al., “Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease,” Hormone and Metabolic Research, vol. 41, no. 12, pp. 855–860, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. J. Iglesias, S. Eiras, R. Piñeiro et al., “Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery,” Revista Espanola de Cardiologia, vol. 59, no. 12, pp. 1252–1260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Jaffer, M. Riederer, P. Shah et al., “Expression of fat mobilizing genes in human epicardial adipose tissue,” Atherosclerosis, vol. 220, no. 1, pp. 122–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Langheim, L. Dreas, L. Veschini et al., “Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 3, pp. H746–H753, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. R. M. Agra, E. Teijeira-Fernández, D. Pascual-Figal et al., “Differential behavior between S100A9 and adiponectin in coronary artery disease. Plasma or epicardial fat,” Life Sciences, vol. 100, no. 2, pp. 147–151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Nasarre, O. Juan-Babot, P. Gastelurrutia et al., “Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels,” Acta Diabetologica, vol. 51, no. 1, pp. 23–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. B. K. Rodiño-Janeiro, A. Salgado-Somoza, E. Teijeira-Fernández, J. R. González-Juanatey, E. Álvarez, and S. Eiras, “Receptor for advanced glycation end-products expression in subcutaneous adipose tissue is related to coronary artery disease,” European Journal of Endocrinology, vol. 164, no. 4, pp. 529–537, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. H. S. Sacks, J. N. Fain, P. Cheema et al., “Depot-Specific overexpression of proinflammatory, redox, endothelial cell, and angiogenic genes in epicardial fat adjacent to severe stable coronary atherosclerosis,” Metabolic Syndrome and Related Disorders, vol. 9, no. 6, pp. 433–439, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. H. S. Sacks, J. N. Fain, P. Cheema et al., “Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone,” Diabetes Care, vol. 34, no. 3, pp. 730–733, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. H. S. Sacks, J. N. Fain, B. Holman et al., “Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3611–3615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Salgado-Somoza, E. Teijeira-Fernández, Á. L. Fernández, J. R. González-Juanatey, and S. Eiras, “Changes in lipid transport-involved proteins of epicardial adipose tissue associated with coronary artery disease,” Atherosclerosis, vol. 224, no. 2, pp. 492–499, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Salgado-Somoza, E. Teijeira-Fernández, Á. Luis Fernandez, J. Ramon Gonzalez-Juanatey, and S. Eiras, “Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 299, no. 1, pp. H202–H209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Salgado-Somoza, E. Teijeira-Fernández, J. Rubio, E. Couso, J. R. González-Juanatey, and S. Eiras, “Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue,” Clinical Endocrinology, vol. 76, no. 1, pp. 51–58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Shibasaki, T. Nishikimi, Y. Mochizuki et al., “Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease,” Regulatory Peptides, vol. 165, no. 2-3, pp. 210–217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Shimabukuro, Y. Hirata, M. Tabata et al., “Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 5, pp. 1077–1084, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Silaghi, V. Achard, O. Paulmyer-Lacroix et al., “Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status,” American Journal of Physiology—Endocrinology and Metabolism, vol. 293, no. 5, pp. E1443–E1450, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Silaghi, H. Silaghi, T. Scridon, R. Pais, and V. Achard, “Glucocorticoid receptors in human epicardial adipose tissue: role of coronary status,” Journal of Endocrinological Investigation, vol. 35, no. 7, pp. 649–654, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Teijeira-Fernandez, S. Eiras, L. G. Shamagian, A. S. Somoza, C. Delgado, and J. R. Gonzalez-Juanatey, “Lower epicardial adipose tissue adiponectin in patients with metabolic syndrome,” Cytokine, vol. 54, no. 2, pp. 185–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Teijeira-Fernandez, S. Eiras, L. Grigorian-Shamagian, A. Fernandez, B. Adrio, and J. R. Gonzalez-Juanatey, “Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension,” Journal of Human Hypertension, vol. 22, no. 12, pp. 856–863, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Teijeira-Fernandez, S. Eiras, L. Grigorian-Shamagian, A. Salgado-Somoza, J. M. Martinez-Comendador, and J. R. Gonzalez-Juanatey, “Diabetic and nondiabetic patients express similar adipose tissue adiponectin and leptin levels,” International Journal of Obesity, vol. 34, no. 7, pp. 1200–1208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Teijeira-Fernandez, S. Eiras, A. Salgado Somoza, and J. R. Gonzalez-Juanatey, “Baseline epicardial adipose tissue adiponectin levels predict cardiovascular outcomes: a long-term follow-up study,” Cytokine, vol. 60, no. 3, pp. 674–680, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Vural, F. Atalar, C. Ciftci et al., “Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome,” Cardiovascular Pathology, vol. 17, no. 6, pp. 392–398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Zhou, Y. Wei, L. Wang et al., “Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease,” Cardiovascular Diabetology, vol. 10, article 2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Dozio, S. Briganti, E. Vianello et al., “Epicardial adipose tissue inflammation is related to vitamin D deficiency in patients affected by coronary artery disease,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 25, no. 3, pp. 267–273, 2015. View at Publisher · View at Google Scholar
  58. H. Imoto-Tsubakimoto, T. Takahashi, T. Ueyama et al., “Serglycin is a novel adipocytokine highly expressed in epicardial adipose tissue,” Biochemical and Biophysical Research Communications, vol. 432, no. 1, pp. 105–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Chechi, P.-G. Blanchard, P. Mathieu, Y. Deshaies, and D. Richard, “Brown fat like gene expression in the epicardial fat depot correlates with circulating HDL-cholesterol and triglycerides in patients with coronary artery disease,” International Journal of Cardiology, vol. 167, no. 5, pp. 2264–2270, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Vokurka, Z. Lacinova, J. Kremen et al., “Hepcidin expression in adipose tissue increases during cardiac surgery,” Physiological Research, vol. 59, no. 3, pp. 393–400, 2010. View at Google Scholar
  61. J. Kremen, M. Dolinkova, J. Krajickova et al., “Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4620–4627, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. H. S. Sacks, J. N. Fain, S. W. Bahouth et al., “Adult epicardial fat exhibits beige features,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 9, pp. E1448–E1455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. J. N. Fain, H. S. Sacks, S. W. Bahouth, D. S. Tichansky, A. K. Madan, and P. S. Cheema, “Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat,” Metabolism: Clinical and Experimental, vol. 59, no. 9, pp. 1379–1386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Baumann, N. Lee, S. Nicoloro et al., “Human epicardial fat shares molecular and morphologic features of omental fat,” Circulation, vol. 128, Article ID A17549, 2013. View at Google Scholar
  65. S. Guauque-Olarte, N. Gaudreault, M.-È. Piché et al., “The transcriptome of human epicardial, mediastinal and subcutaneous adipose tissues in men with coronary artery disease,” PLoS ONE, vol. 6, no. 5, Article ID e19908, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Nichols, N. Townsend, P. Scarborough, and M. Rayner, “Cardiovascular disease in Europe 2014: epidemiological update,” European Heart Journal, vol. 35, no. 42, pp. 2950–2959, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Toczyłowski, M. Gruca, and M. Baranowski, “Epicardial adipose tissue and its role in cardiac physiology and disease,” Postepy Higieny i Medycyny Doswiadczalnej, vol. 67, pp. 584–593, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Çetin, T. Erdoğan, S. A. Kocaman et al., “Increased epicardial adipose tissue in patients with isolated coronary artery ectasia,” Internal Medicine, vol. 51, no. 8, pp. 833–838, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. M. L. McKenney, K. A. Schultz, J. H. Boyd et al., “Epicardial adipose excision slows the progression of porcine coronary atherosclerosis,” Journal of Cardiothoracic Surgery, vol. 9, article 2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. P. M. Kang and S. Izumo, “Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases,” Trends in Molecular Medicine, vol. 9, no. 4, pp. 177–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Xiao, B. Sun, M. Li, Y. Wu, and X.-B. Sun, “A novel adipocytokine visfatin protects against H2O2-induced myocardial apoptosis: a missing link between obesity and cardiovascular disease,” Journal of Cellular Physiology, vol. 228, no. 3, pp. 495–501, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. J. M. Hare, “Oxidative stress and apoptosis in heart failure progression,” Circulation Research, vol. 89, no. 3, pp. 198–200, 2001. View at Google Scholar · View at Scopus
  73. K.-H. Cheng, C.-S. Chu, K.-T. Lee et al., “Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease,” International Journal of Obesity, vol. 32, no. 2, pp. 268–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Noshad, H. Argani, N. Nezami et al., “Arterial atherosclerosis in patients with chronic kidney disease and its relationship with serum and tissue,” Iranian Journal of Kidney Diseases, vol. 3, no. 4, pp. 203–209, 2009. View at Google Scholar · View at Scopus
  75. A. P. Pilbrow, B. R. Palmer, C. M. Frampton et al., “Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failure,” Hypertension, vol. 49, no. 2, pp. 322–327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Roubicek, M. Dolinkova, J. Blaha et al., “Increased angiotensinogen production in epicardial adipose tissue during cardiac surgery: possible role in a postoperative insulin resistance,” Physiological Research, vol. 57, no. 6, pp. 911–917, 2008. View at Google Scholar
  77. J. Scheller, A. Chalaris, D. Schmidt-Arras, and S. Rose-John, “The pro- and anti-inflammatory properties of the cytokine interleukin-6,” Biochimica et Biophysica Acta, vol. 1813, no. 5, pp. 878–888, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Hou, B. C. Tieu, S. Ray et al., “Roles of IL-6-gp130 signaling in vascular inflammation,” Current Cardiology Reviews, vol. 4, no. 3, pp. 179–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Nair, M. Ghatge, V. V. Kakkar, and J. Shanker, “Network analysis of inflammatory genes and their transcriptional regulators in coronary artery disease,” PLoS ONE, vol. 9, no. 4, Article ID e94328, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. D. Menendez, A. Inga, and M. A. Resnick, “The expanding universe of p53 targets,” Nature Reviews Cancer, vol. 9, no. 10, pp. 724–737, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. J. A. Royds and B. Iacopetta, “p53 and disease: when the guardian angel fails,” Cell Death & Differentiation, vol. 13, no. 6, pp. 1017–1026, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. K. H. Vousden and D. P. Lane, “p53 in health and disease,” Nature Reviews Molecular Cell Biology, vol. 8, no. 4, pp. 275–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Mercer, M. Mahmoudi, and M. Bennett, “DNA damage, p53, apoptosis and vascular disease,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 621, no. 1-2, pp. 75–86, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. G. L. Semenza, “Mechanisms of disease: oxygen sensing, homeostasis, and disease,” The New England Journal of Medicine, vol. 365, no. 6, pp. 537–547, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Huang, R. P. Hickey, J. L. Yeh et al., “Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart,” The FASEB Journal, vol. 18, no. 10, pp. 1138–1140, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. P. Trayhurn, B. Wang, and I. S. Wood, “Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?” British Journal of Nutrition, vol. 100, no. 2, pp. 227–235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. N. Halberg, T. Khan, M. E. Trujillo et al., “Hypoxia-inducible factor 1α induces fibrosis and insulin resistance in white adipose tissue,” Molecular and Cellular Biology, vol. 29, no. 16, pp. 4467–4483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. N.-H. Kim and P. M. Kang, “Apoptosis in cardiovascular diseases: mechanism and clinical implications,” Korean Circulation Journal, vol. 40, no. 7, pp. 299–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Gill, R. Mestril, and A. Samali, “Losing heart: the role of apoptosis in heart disease—a novel therapeutic target?” The FASEB Journal, vol. 16, no. 2, pp. 135–146, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. M. N. Sack, R. M. Smith, and L. H. Opie, “Tumor necrosis factor in myocardial hypertrophy and ischaemia—an anti-apoptotic perspective,” Cardiovascular Research, vol. 45, no. 3, pp. 688–695, 2000. View at Publisher · View at Google Scholar · View at Scopus